Pacific Biosciences of California Future Growth
How is Pacific Biosciences of California forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Future Growth Score
2/6Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
17.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 404 | -215 | -137 | -93 | 3 |
12/31/2024 | 267 | -272 | -215 | -153 | 7 |
12/31/2023 | 175 | -308 | -256 | -219 | 7 |
9/30/2022 | 137 | -299 | -249 | -234 | N/A |
6/30/2022 | 140 | -206 | -224 | -212 | N/A |
3/31/2022 | 135 | -175 | -176 | -167 | N/A |
12/31/2021 | 131 | -181 | -117 | -111 | N/A |
9/30/2021 | 122 | -37 | -97 | -94 | N/A |
6/30/2021 | 106 | -77 | -73 | -71 | N/A |
3/31/2021 | 92 | -59 | -80 | -79 | N/A |
12/31/2020 | 79 | 29 | 18 | 20 | N/A |
9/30/2020 | 80 | -46 | 14 | 16 | N/A |
6/30/2020 | 83 | -51 | 15 | 16 | N/A |
3/31/2020 | 90 | -53 | 21 | 22 | N/A |
12/31/2019 | 91 | -84 | -81 | -78 | N/A |
9/30/2019 | 82 | -115 | -82 | -79 | N/A |
6/30/2019 | 79 | -111 | -78 | -76 | N/A |
3/31/2019 | 76 | -109 | -76 | -73 | N/A |
12/31/2018 | 79 | -103 | -68 | -66 | N/A |
9/30/2018 | 84 | -93 | -71 | -68 | N/A |
6/30/2018 | 89 | -90 | -77 | -71 | N/A |
3/31/2018 | 88 | -93 | -78 | -70 | N/A |
12/31/2017 | 93 | -92 | -78 | -68 | N/A |
9/30/2017 | 94 | -90 | -72 | -60 | N/A |
6/30/2017 | 96 | -86 | -69 | -58 | N/A |
3/31/2017 | 97 | -79 | -75 | -64 | N/A |
12/31/2016 | 91 | -74 | -76 | -68 | N/A |
9/30/2016 | 101 | -57 | -62 | -56 | N/A |
6/30/2016 | 90 | -37 | N/A | -56 | N/A |
3/31/2016 | 94 | -31 | N/A | -44 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PACB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PACB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PACB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PACB's revenue (31.8% per year) is forecast to grow faster than the US market (7% per year).
High Growth Revenue: PACB's revenue (31.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PACB is forecast to be unprofitable in 3 years.